There are more than 290,000 people estimated to be living in the United States with a spinal cord injury. Previously, it has been shown that it is possible to restore some function to young and healthy patients within a few years of injury. Now, researchers show spinal cord stimulation can immediately restore some voluntary movement and autonomic functions such as cardiovascular, bowel, and bladder years after a paralyzing injury without any significant rehabilitation.
“This was an opportunity to use epidural stimulation, combine my background in mathematics, collaborate with people from multiple disciplines including biomedical engineering and set up a truly innovative trial,” said Dr. David Darrow, a neurosurgery resident at the University of Minnesota Medical School and a lead investigator for the E-STAND Clinical trial. He is also a senior neurosurgery resident at Hennepin Healthcare and University of Minnesota Medical Center. “We wanted to push the envelope for patients. Once we determined it worked, we moved on to knocking down other barriers to translation to patient care.”
In a study recently published in the Journal of Neurotrauma, Darrow and his colleagues implanted the first series of female patients who both suffered devastating traumatic spinal cord injury. Both patients had no lower body function whatsoever and MRIs showing very little residual spinal cord at the level of injury. The two women were five and ten years from injury and in their 5th and 6th decade of life, which is much closer to the average patient with spinal cord injury compared to the work of other investigators.
“Enabling someone to move her legs more than 10 years after being paralyzed from spinal cord injury has been one of the greatest moments of my career,” said Uzma Samadani, MD, PhD, Associate Professor in the Department of Neurosurgery University of Minnesota Medical School and Neurosurgeon with Hennepin Healthcare. “I am grateful to my colleagues for their mutual hard work during the 2 years it took to get from idea to the first operation.”
In this study, researchers expanded the inclusion guidelines of who could receive epidural stimulation.
“We believe that we are studying a population that is much closer to the general population of patients with spinal cord injury,” said Darrow. “We have opened the doors to so many more patients with traumatic spinal cord injury.”
“While we are excited for all this could mean for patients, there is still a lot of research to be done, both with this therapy and through other avenues, many of which we are studying at the University of Minnesota,” said Ann M. Parr, MD, PhD, Assistant Professor in the Department of Neurosurgery at the University of Minnesota Medical School. Dr. Parr has an active translational spinal cord injury research laboratory at the Stem Cell Institute.
This work was made possible by a grant through the Minnesota Office of Higher Education SCI/TBI Grant Program and collaboration of an interdisciplinary group spread across four institutions. The stimulation devices were a gift from Abbott (formerly St. Jude’s).
The Latest on: Spinal cord stimulation
via Google News
The Latest on: Spinal cord stimulation
- Complications of epidural spinal stimulation: lessons from the past and alternatives for the futureon June 23, 2020 at 10:42 am
Over the past decade, an increasing number of studies have demonstrated that epidural spinal cord stimulation (SCS) can successfully assist with neurorehabilitation following spinal cord injury (SCI).
- Riding 500 km to help a friend stand upon June 22, 2020 at 1:59 am
Three friends covering 500km on Vancouver Island for Shim's Ride fundraiser, to help a friend's recovery after severe training ride injury ...
- High-Frequency Spinal Cord Stimulation Eases Diabetic Neuropathy Painon June 15, 2020 at 7:51 am
Those results included 103 patients randomized to conventional medical management alone, and 113 who received medical management plus the spinal cord stimulator, which Dr. Strand described as a ...
- Global Spinal Cord Stimulation System Market 2020 Industry Share, Size, Drivers, Challenges, Latest Trends and CAGR Status and Forecast to 2026on June 15, 2020 at 12:48 am
Final Report will add the analysis of the impact of COVID-19 on this industry” Global “Spinal Cord Stimulation ...
- 6 spine, orthopedic device company acquisitions in 2020 — Medtronic, Orthofix & moreon June 11, 2020 at 7:46 am
Here are six spine and orthopedic device company acquisitions in 2020 so far: 1. In May, spinal implant developer Safe Orthopaedics entered into exclusive negotiations to acquire LCI Medical, which ...
- Gtx Medical receives breakthrough device designation for implanted spinal stimulation systemon June 10, 2020 at 4:22 pm
The U.S. FDA granted Gtx Medical BV a breakthrough device designation for its implantable Go-2 Targeted Epidural Spinal Stimulation (TESS) system. The device enabled patients who had sustained ...
- GTX medical Granted FDA Breakthrough Device Designation for Go-2 Targeted Epidural Spinal Stimulation (TESS) Systemon June 9, 2020 at 3:39 pm
EINDHOVEN, Netherlands & LAUSANNE, Switzerland--(BUSINESS WIRE)--GTX medical (GTX), today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device Designation for ...
- GTX medical Granted FDA Breakthrough Device Designation for Go-2 Targeted Epidural Spinal Stimulation (TESS) Systemon June 9, 2020 at 2:26 am
GTX medical (GTX), today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its implantable Go-2 system which was designed to promote the ...
- GTX medical Granted FDA Breakthrough Device Designation for Go-2 Targeted Epidural Spinal Stimulation (TESS) Systemon June 9, 2020 at 2:04 am
The Go-2 System provides Targeted Epidural Spinal Stimulation (TESS) therapy, promoting the recovery of leg motor functions and neurological control in adults with spinal cord injuries (SCI).
- Fed. Circ. Backs PTAB Trim Of Boston Scientific Spine Pain IPon May 29, 2020 at 5:44 pm
In reaching that conclusion the board found that one of the patents disclosed a key feature of Boston Scientific's spinal cord stimulation system — a detachable part used to implant the device.
via Bing News